Noninvasive assessment of the lung inflammation-fibrosis axis by targeted imaging of CMKLR1
Science Advances · 21.06.2024 · 10 (25)
DOI: 10.1126/sciadv.adm9817 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 21.06.2024. Verfasst von Philip Z Mannes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Pneumonia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Precision management of fibrotic lung diseases is challenging due to their diverse clinical trajectories and lack of reliable biomarkers for risk stratification and therapeutic monitoring. Here, we validated the accuracy of CMKLR1 as an imaging biomarker of the lung inflammation-fibrosis axis. By analyzing single-cell RNA sequencing datasets, we demonstrated CMKLR1 expression as a transient signature of monocyte-derived macrophages (MDMφ) enriched in patients with idiopathic pulmonary fibrosis (IPF). Consistently, we identified MDMφ as the major driver of the uptake of CMKLR1-targeting peptides in a murine model of bleomycin-induced lung fibrosis. Furthermore, CMKLR1-targeted positron emission tomography in the murine model enabled quantification and spatial mapping of inflamed lung regions infiltrated by CMKLR1-expressing macrophages and emerged as a robust predictor of subsequent lung fibrosis. Last, high CMKLR1 expression by bronchoalveolar lavage cells identified an inflammatory endotype of IPF with poor survival. Our investigation supports the potential of CMKLR1 as an imaging biomarker for endotyping and risk stratification of fibrotic lung diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA.
- Medical Scientist Training Program, University of Pittsburgh, Pittsburgh, PA, USA.
- Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, CT, USA.
- Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA.
- Center for Aging and Population Health, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
ORCID-Profile: Philip Z Mannes, Taylor S Adams, Samaneh Farsijani, Clayton E Barnes, Joseph D Latoche, Jessie R Nedrow, Farida Ahangari, Naftali Kaminski, Janet S Lee, Sina Tavakoli
Förderung
- NCATS NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- NIBIB NIH HHS
- NIA NIH HHS
Zitieren
APA
Mannes, P. Z., Adams, T. S., Farsijani, S., Barnes, C. E., Latoche, J. D., Day, K. E., Nedrow, J. R., Ahangari, F., Kaminski, N., Lee, J. S., & Tavakoli, S. (2024). Noninvasive assessment of the lung inflammation-fibrosis axis by targeted imaging of CMKLR1. Science Advances, 10(25). https://doi.org/10.1126/sciadv.adm9817
Vancouver
Mannes PZ, Adams TS, Farsijani S, Barnes CE, Latoche JD, Day KE, et al. Noninvasive assessment of the lung inflammation-fibrosis axis by targeted imaging of CMKLR1. Science Advances. 2024;10(25). doi:10.1126/sciadv.adm9817
BibTeX
@article{Mannes2024,
author = {Mannes, Philip Z and Adams, Taylor S and Farsijani, Samaneh and Barnes, Clayton E and Latoche, Joseph D and Day, Kathryn E and Nedrow, Jessie R and Ahangari, Farida and Kaminski, Naftali and Lee, Janet S and Tavakoli, Sina},
title = {Noninvasive assessment of the lung inflammation-fibrosis axis by targeted imaging of CMKLR1},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {25},
doi = {10.1126/sciadv.adm9817}
}
EUVIMED